Note: Ingredients listed on restricted chemical lists
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
557-04-0
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
N/A
General Information
Revision date
2025-11-24
Product name
Abacavir and Lamivudine Tablets USP, 600 mg and 300 mg
1.2.1 Relevant identified uses
Pharmaceutical product used as Anti-retroviral medication
Manufacturer Name
Hetero Labs Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Fire and Explosion Health Expected to be non-combustible. Abacavir and lamivudine tablets are contraindicated in patients: • who have the HLA-B*5701 allele • with prior hypersensitivity reaction to abacavir or lamivudine. • with moderate or severe hepatic impairment
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.